The current study was undertaken to analyse the prognostic role of Th1 polarised T cells expressing T-bet in intratumoral lymphoid structures, in patients undergoing neoadjuvant chemotherapy incorporating or not trastuzumab and taxane for HER2-overexpressing breast cancer. Here, ERBB2 is linked to breast cancer.